Why Moderna Stock Surged Today
Moderna rose 12.15% as the NIH-backed effort aims to speed personalized cancer vaccine research, according to Benzinga Pro data.
6 Articles
6 Articles
New details have emerged about an initiative that will start in December to accelerate vaccine development, similar to the successful Covid-19 vaccine campaign
A large-scale public-private partnership is being launched in the United States to accelerate the development of cancer vaccines. The National Cancer Institute (NCI) says that new types of personalized therapeutic vaccines are so promising that they require a broad national effort, the New York Times reported, citing a report that is still unpublished.
Cancer Vaccine Stocks Gaining Attention After Moderna Shares Jumped On US Backing
Cancer vaccines just moved from science headline to front-page market story after a US government push modeled on Operation Warp Speed sent Moderna up 9% in a single session and lifted peers like Pfizer, BioNTech and Merck. That kind of spotlight can reshape where capital flows next and who gets left behind. This article breaks down three US-listed cancer vaccine and immuno-oncology stocks exposed to this news and what that might mean for your w…
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
